Chemotherapy Sensitivity Testing in Euless, TX
Chemotherapy sensitivity testing is a cornerstone of integrative cancer therapy (ICT). This type of testing is one of the first steps of an integrative cancer therapy treatment plan. By testing each individual patient's chemotherapy sensitivity, an ICT provider is able to personalize the following treatments for each individual patient.
Request more information on chemotherapy sensitivity testing today: Call (817) 203-2760 or contact Ms. Jessica Stangenwald online.
What is Chemotherapy Sensitivity Testing?
Chemotherapy sensitivity testing is diagnostic test used as a part of integrative cancer therapy (ICT). Integrative cancer therapy combines alternative cancer treatments, including low-dose metronomic chemotherapy, into a specialized treatment plan for each patient.
Chemotherapy sensitivity testing often leads to low-dose metronomic chemotherapy, in which small doses of chemo medication are delivered over a consistent period of time. This is contrary to traditional chemotherapy, which delivers high doses of medication infrequently.
Some of the benefits of chemotherapy sensitivity testing and low-dose chemotherapy include:
- More personalized care
- Reduced chemotherapy symptoms (vomiting, hair loss, pain)
- Inhibition of angiogenesis (the development of blood vessels that feed the tumor)
How Does Chemotherapy Sensitivity Testing Work?
The chemotherapy sensitivity testing typically includes one or both of two important tests: evidence-based molecular profiling and whole cell cytometric profiling.
- Evidence-based molecular profiling: This is a comprehensive diagnostic test that identifies the unique gene and proteins found in cancerous tumors. During this test, a special molecular profile is created that helps Integrative Cancer Therapy doctors match patients with the appropriate therapies for their needs. During this test, the most potentially effective chemotherapy options are identified which enables highly individuated cancer care.
- Whole cell cytometric profiling: This is a process where living cancer cells are obtained from the patient, and then exposed to a broad range of chemotherapy drugs. This determines the true cell killing ability of each drug. This helps the Integrative Cancer Therapy doctor determine which drugs and dosages are appropriate for the individual cancer case.
Cytometric profiling has been shown to identify the synergy between cancer drug combinations. Certain cancer drugs are somewhat effective on their own, but may become extremely effective when combined with another drug.
Request Chemotherapy Sensitivity Testing Information
Chemotherapy sensitivity testing is just the first step of an integrative cancer therapy treatment plan. Request more information about chemotherapy testing and low-dose chemotherapy today: call (817) 203-2760 or contact Ms. Jessica Stangenwald online.
The New You Medical & Infusion Clinic
Address100 Grapevine Hwy
Hurst, TX 76054
10:00 am - 6:00 pm
Tue: 10:00 am - 6:00 pm
Wed: 10:00 am - 6:00 pm
Thu: 10:00 am - 6:00 pm